ICYMI: An Observational Blood Cancer Study is Starting to Recruit Patients
source: pixabay.com

ICYMI: An Observational Blood Cancer Study is Starting to Recruit Patients

According to a story from Financial Buzz, the precision oncology company Notable has recently announced that it has opened enrollment for a new observational clinical trial that will focus on…

Continue Reading ICYMI: An Observational Blood Cancer Study is Starting to Recruit Patients
Mutations are the Key to Predicting Outcomes in Myeloproliferative Neoplasms, Study Says
Katzenfee50 / Pixabay

Mutations are the Key to Predicting Outcomes in Myeloproliferative Neoplasms, Study Says

According to a story from Cure Today, a recent study has found that identifying mutations in patients with myeloproliferative neoplasms may be the key in predicting outcomes, such as disease…

Continue Reading Mutations are the Key to Predicting Outcomes in Myeloproliferative Neoplasms, Study Says
Drug For Chronic Myelogenous Leukemia Gets Expanded Approval From The FDA
source: pixabay.com

Drug For Chronic Myelogenous Leukemia Gets Expanded Approval From The FDA

According to a story from cnbc.com, the pharmaceutical company Novartis recently announced that their anticancer drug Tasigna has been approved for the treatment of patients one year or older that…

Continue Reading Drug For Chronic Myelogenous Leukemia Gets Expanded Approval From The FDA
Don’t Miss These Events for CML Caregivers!
Marisa04 / Pixabay

Don’t Miss These Events for CML Caregivers!

Whether you’re dealing with chronic myelogenous leukemia (CML), chondrosarcoma, neuroblastoma, or the host of other pediatric cancer diagnoses, it’s the actual diagnosis that can take your breath away. You can…

Continue Reading Don’t Miss These Events for CML Caregivers!
Close Menu